Zynerba Pharms

ZYNE NASDAQ
13.94
+0.30
+2.20%
已收盘, 17:41 07/15 EDT
开盘
13.60
昨收
13.64
最高
14.28
最低
13.19
成交量
111.68万
成交均量(3M)
233.77万
52周最高
16.47
52周最低
2.750
换手率
5.30%
市值
2.94亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Zynerba Pharms ZYNE股票价格,Zynerba Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which is a non-psychoactive cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. ZYN002 is in Phase II clinical development in patients with refractory epilepsy, in patients with osteoarthritis of the knee, as well as in patients with Fragile X syndrome. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through the skin and into the circulatory system through a patch. ZYN001 is targeting two pain indications, fibromyalgia and peripheral neuropathic pain.
展开 >

最近浏览

名称
价格
涨跌幅